Results 231 to 240 of about 31,826 (289)
Some of the next articles are maybe not open access.
INTRASYNOVIAL INSTILLATION OF TRIAMCINOLONE ACETONIDE
Journal of the American Medical Association, 1960The intrasynovial injection of triamcinolone acetonide for the relief of arthritic or bursitic pain was carried out in 67 patients. They were selected because of pain, tenderness, or limitation of motion, occurring primarily in a single joint or bursa. The injections were into a joint cavity in 25 patients and into a bursa in 42.
openaire +3 more sources
Terminal neuromas treated with triamcinolone acetonide
Journal of Surgical Research, 1973Abstract Seven squirrel monkeys had common digital nerves in the palm and sole ligated and divided. Triamcinolone was injected around some of the divided nerves at the initial operation or at 2 or 2 and 6 weeks post-operatively. Control nerves received saline injections at the same time.
Bryce L. Munger +2 more
openaire +4 more sources
Fluocinolone Acetonide in Propylene Glycol
Archives of Dermatology, 1963Eighty patients with varying types of inflammatory dermatoses were treated with a liquid solution containing fluocinolone acetonide 0.01% dissolved in propylene glycol. * While the over-all results were not as good as those reported for the 0.025% vanishing cream preparation, it was particularly effective for some patients whose dermatoses involved the
openaire +3 more sources
Triamcinolone acetonide injection for laryngeal stenosis
The Journal of Laryngology & Otology, 1975Three cases with acquired laryngeal stenosis have been presented. They were treated by percutaneous intralesional injection of triamcinolone acetonide using mirror laryngoscopy. The laryngeal airway and the phonation have been satisfactory for a period of two to six years of close follow-up.
I. Y. Vered, G. Rosen
openaire +3 more sources
, 2016
A protected catechol-containing epoxide monomer, catechol acetonide glycidyl ether (CAGE), is introduced. CAGE is conveniently obtained in three steps and enables the incorporation of surface-active catechol moieties into a broad variety of hydrophilic ...
K. Niederer +4 more
semanticscholar +1 more source
A protected catechol-containing epoxide monomer, catechol acetonide glycidyl ether (CAGE), is introduced. CAGE is conveniently obtained in three steps and enables the incorporation of surface-active catechol moieties into a broad variety of hydrophilic ...
K. Niederer +4 more
semanticscholar +1 more source
Journal of Oral Pathology & Medicine, 1992
Twenty patients with oral lichen planus and topically treated with fluocinolone acetonide in orabase 0.1% (FAO) were compared with 20 treated with triamcinolone acetonide in orabase 0.1% (TAO). During 4 wk of treatment the lesions in 13 of 19 patients could be effectively cured with FAO whereas only 8 of 19 patients were cured with TAO.
W. Taweesap +3 more
openaire +3 more sources
Twenty patients with oral lichen planus and topically treated with fluocinolone acetonide in orabase 0.1% (FAO) were compared with 20 treated with triamcinolone acetonide in orabase 0.1% (TAO). During 4 wk of treatment the lesions in 13 of 19 patients could be effectively cured with FAO whereas only 8 of 19 patients were cured with TAO.
W. Taweesap +3 more
openaire +3 more sources
Preparation of [11C]triamcinolone acetonide
Applied Radiation and Isotopes, 1994Abstract Triamcinolone acetonide is commercially available in a variety of formulations for local administration as an anti-inflammatory agent. In order to evaluate the effectiveness of various dosage methods and the kinetics of subsequent absorption and distribution, the acetonide was labeled with carbon-11 for use in PET studies.
Kirk G. Bordeaux +2 more
openaire +2 more sources
Triamcinolone acetonide-loaded lipid nanocapsules for ophthalmic applications.
International journal of pharmaceutics, 2020M. L. Formica +5 more
semanticscholar +1 more source
Intravitreal Triamcinolone Acetonide
Retina, 2004Gholam A. Peyman, Darius M. Moshfeghi
openaire +3 more sources